Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
siRNA
Fierce Biotech
China looks to ban foreign acquisitions of key biotech platforms
Beijing is looking to block foreign acquisitions of proprietary cell and gene therapy, siRNA and pathogen gain-of-function platforms.
Angus Liu
Oct 16, 2026 10:38am
Alnylam drafts $250M upgrade to its Mass. drug factory
Dec 17, 2025 10:12am
Alnylam's ATTR-CM launch blows past estimates again
Oct 30, 2025 8:00am
Novartis-Argo, Eisai, Henlius—Fierce Pharma Asia
Sep 5, 2025 9:00am
With Alzheimer's in its sights, Alnylam discusses siRNA delivery
Jun 7, 2022 8:00am